Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
- 1Department of Surgery, General Hospital Nasice, Nasice, Croatia
- 2Department of Clinical Medicine, Faculty of Dental Medicine and Health Osijek, Osijek, Croatia
- 3PhD Program Translational Research in Biomedicine—TRIBE, School of Medicine, University of Split, Split, Croatia
- 4Department of Pharmacology, School of Medicine, University of Zagreb, Zagreb, Croatia
- 5Clinical Department of Surgery, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia
- 6Department of Surgery, Faculty of Medicine, University of Osijek, Osijek, Croatia
- 7Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia
- 8Internal Diseases Clinic, Faculty of Veterinary Medicine Zagreb, Zagreb, Croatia
- 9Department of Anatomy and Neuroscience, Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia
- 10Department of Diagnostic and Interventional Radiology, University Hospital Centre, Zagreb, Croatia
- 11Department of Surgery, School of Medicine, University of Zagreb, Zagreb, Croatia
A Corrigendum on
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
by Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021). Front. Pharmacol. 12:718147. doi:10.3389/fphar.2021.718147
In the published article, there was an error in affiliations 2 and 3. Instead of “2Department of Clinical Medicine, Faculty of Dental Medicine and Health Osijek, Zagreb, Croatia; 3PhD Program Translational Research in Biomedicine—TRIBE, School of Medicine, University of Split, Zagreb, Croatia.,” it should be “2Department of Clinical Medicine, Faculty of Dental Medicine and Health Osijek, Osijek, Croatia; 3PhD Program Translational Research in Biomedicine—TRIBE, School of Medicine, University of Split, Split, Croatia.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema
Citation: Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Blagaic AB and Sikiric P (2022) Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats. Front. Pharmacol. 12:844785. doi: 10.3389/fphar.2021.844785
Received: 29 December 2021; Accepted: 29 December 2021;
Published: 21 January 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Tepes, Gojkovic, Krezic, Zizek, Vranes, Madzar, Santak, Batelja, Milavic, Sikiric, Kocman, Simonji, Samara, Knezevic, Barisic, Lovric, Strbe, Kokot, Sjekavica, Kolak, Skrtic, Seiwerth, Blagaic and Sikiric. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Predrag Sikiric, c2lraXJpY0BtZWYuaHI=